Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
How to Trip Rapid Review
Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)
Step 2: press
Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.
as indicated by ulcer severity or chronicity, and if treated, document treatment and its duration. (Bryant et al., 1983; Lewis et al 1988; Milne et al, 2009) e.g. fistulae, abscesses, osteomyelitis, bacteremia, cellulitis, cancer, heterotopic bone formation 5. For individuals with a PU it is important to perform differential diagnoses (e.g. skin tear, Herpes lesions, incontinence-associated dermatitis, candidiasis, arterial insufficiency ulcer) to improve accuracy of pressure ulcer diagnosis (Konishi et al (...) ) E. SURGICAL INTERVENTIONS (Brown et al., 2007;Isik et al. 1997; Wong & Ip 2006; Yamamoto et al 1997) 1. Direct closure (Whitney et al 2006) seldom helps unless pressure source is eliminated and PU is small (Brown et al., 2007) 2. Flaps: Myocutaneous free, fasciocutaneous, cutaneous (Ichioka et al 2007; Lemaire et al 2008; Wong & Ip 2006; Rennert et al 2009; Yamamoto et al 1997) 3. Skin grafts (Whitney et al., 2006) though they exhibit ?poor take? over exposed bone (Brown et al., 2007) 4
immunocompromised patients, namely recurrent oral, vaginal, and cutaneouscandidiasis, during 2015-16. Antifungal susceptibility testing of fluconazole against clinical Candida species was performed according to Clinical and Laboratory Standards Institute guidelines. Ergosterol content and gene expression profiling of sterol 14α-demethylase (ERG11) gene in fluconazole-susceptible and -resistant C. albicans were investigated.The specimens consisted of C. albicans (46.67%), Candida krusei (41.67%), and Candida
fluconazole-resistant and 20 susceptible C. albicans isolates obtained from oral, vaginal, and cutaneous tissues of patients with candidiasis were evaluated. The efficacy and minimum inhibitory concentrations (MICs) of Zataria multiflora, Geranium herbarum,Lavendula officinalis,Cuminum, cyminum,Allium heamanthoides, and Artemisia sieberi essential oils against C. albicans were determined on the basis of a reference method for broth microdilution susceptibility testing of yeasts as suggested by Clinical (...) essential oils against both azoles-resistant and azoles-susceptible isolates were similar. Given the documented resistance of different Candida species to synthetic and chemical antifungals, these essential oils are effective replacement treatments for cutaneous and mucosal Candida infections, especially in resistant or recurrent cases.
Risks of Ruxolitinib in STAT1 Gain-of-Function-Associated Severe Fungal Disease Heterozygous STAT1 gain-of-function (GOF) mutations are associated with chronic mucocutaneous candidiasis and a broad spectrum of infectious, inflammatory, and vascular manifestations. We describe therapeutic failures with the Janus Kinase (JAK) inhibitor ruxolitinib in 2 STAT1 GOF patients with severe invasive or cutaneous fungal infections.
contributes to a thickening of skin and soft tissue, which manifests as coarsening and enlargement of facial and acral structures. Stimulation of the thyrotropin receptor in hyperthyroidism results in mesenchymal tissue proliferation and consequent pretibial myxedema; other associated cutaneous features include onycholysis, and hyperhidrosis. Individuals with hypothyroidism exhibit cold, dry skin and brittle hair as well as a jaundice-like appearance due to carotene excess. The cutaneous features (...) features including chronic mucocutaneous candidiasis, vitiligo, and alopecia areata. This paper highlights the underlying pathophysiology, dermatologic manifestations, and treatment of the aforementioned endocrine disorders.
antagonists in? iximab and adali- mumab. 75 Other infections that have been reported in patients treated with etanercept in postmarketing studies include endemic fungi, atypical mycobacte- ria, candidiasis, aspergillosis, cytomegalovirus, herpes zoster, Pneumocystis , and Listeria monocytogenes . There has been substantial controversy regarding the use of TNF antagonists in patients with cardio- myopathy, resulting in a black box warning from the FDA for in? iximab use in patients with New York Heart
population 41 (Table 10). The cumulative incidence of de novo cancer after LT increases from 3% to 5% at 1 to 3 years to 11% to 20% at 10 years after LT. 42,43 Cutaneous malignancies are the most common form of malignancy in recipients of solid organ transplants, but cigarette smokers are at increased risk of developing lung cancer and oropha- ryngeal cancer, and the rate of colon cancer is increased in patients undergoing transplantation for PSC because of the comorbid risk from in?ammatory bowel (...) recurrences. Recommendations 41. All LT recipients should see a dermatologist af- ter transplantation to assess cutaneous lesions, with at least an annual evaluation by a derma- tologist 5 years or more after transplantation (grade 1, level A). 42. Patients with PSC and in?ammatory bowel dis- ease or other established risk factors for colo- rectal cancer should undergo an annual screening colonoscopy with biopsies. Colec- tomy, including continence-preserving pouch operations, should be considered when
A. Stevens, on behalf of the American Thoracic Society Fungal Working Group THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY (ATS) WAS APPROVED BY THE ATS BOARD OF DIRECTORS, MAY 2010 CONTENTS Introduction Methods Antifungal Agents: General Considerations Polyenes Triazoles Echinocandins Treatment of Fungal Infections Histoplasmosis Sporotrichosis Blastomycosis Coccidioidomycosis Paracoccidioidomycosis Cryptococcosis Aspergillosis Candidiasis Pneumocystis Pneumonia Treatment of Other Fungi (...) mycoses, including histoplasmosis, sporotrichosis, blastomycosis, and coccidioidomycosis; fungal infections of special concern for immune-compromised and critically ill patients, including crypto- coccosis, aspergillosis, candidiasis, and Pneumocystis pneumonia; andrareandemergingfungalinfections. Keywords: fungal pneumonia; amphotericin; triazole antifungal; echinocandin The incidence, diagnosis, and clinical severity of pulmonary fungal infections have dramatically increased in recent years
Use of cost effective and rapid molecular tools for identification of Candida species, opportunistic pathogens Candidiasis is a widespread fungal infection caused by different Candida species. Rapid identification of Candida species in clinical laboratory is becoming increasingly important since the identification and discrimination of ethological agents for early treatment. We aimed at molecular identification of commonly Candida species isolated from clinical samples by using both PCR-RFLP (...) assay and amplification of hwp1 gene.Clinical samples comprising of vaginal specimens ,cutaneous, sputum, bronchoalveolar lavage(BAL,( and blood cultures were recovered from suspected patients. Candida isolates were initially identified phenotypically and confirmed by molecular approaches based on restriction fragment length polymorphism (PCR-RFLP (with MspI restriction enzyme. Amplification of hwp1 gene was performed for discrimination of C. albicans from C. dubliniensis and C.africana.The most
Dual T cellâ€“ and B cellâ€“intrinsic deficiency in humans with biallelic RLTPR mutations Combined immunodeficiency (CID) refers to inborn errors of human T cells that also affect B cells because of the T cell deficit or an additional B cell-intrinsic deficit. In this study, we report six patients from three unrelated families with biallelic loss-of-function mutations in RLTPR, the mouse orthologue of which is essential for CD28 signaling. The patients have cutaneous and pulmonary allergy (...) , as well as a variety of bacterial and fungal infectious diseases, including invasive tuberculosis and mucocutaneous candidiasis. Proportions of circulating regulatory T cells and memory CD4+ T cells are reduced. Their CD4+ T cells do not respond to CD28 stimulation. Their CD4+ T cells exhibit a "Th2" cell bias ex vivo and when cultured in vitro, contrasting with the paucity of "Th1," "Th17," and T follicular helper cells. The patients also display few memory B cells and poor antibody responses. This B
Exclusion Criteria: Patients affected by kidney insufficiency, presenting a seric creatinine higher than 2.5 mg/dl. Medical history of allergy to proteins, or other allergies that could lead to a safety problem if the patient joins the present clinical trial. Acute infectious disease at the moment of enrollment. Chronic infectious disease affecting directly or indirectly the anatomical area that is going to be operated (it includes tuberculosis, brucellosis, chronic candidiasis and cutaneous chronic
may be altered in these lesions.To investigate whether patients with OLP/OLL have (i) altered distribution of filaggrin in the oral mucosa; (ii) a higher incidence of mutations in the filaggrin gene (FLG); (iii) active dermatoses, apart from cutaneous LP, than healthy controls; and (iv) patients with OLP/OLL and a defect in the FLG have more widespread oral lesions and report more symptoms than OLP/OLL patients without a concomitant defect in the FLG.Forty-nine Caucasian patients (42 women and 7 (...) men, mean age 61.0 ± 10.3 years), with symptomatic OLP, OLL or stomatitis, and 29 matched healthy controls underwent a clinical oral and dermatological examination, oral mucosal biopsy and filaggrin genotyping (testing for R2447X, R501X, 2282del4). Smear tests for Candida spp. were performed in all patients to exclude oral candidiasis. Immunohistochemistry were performed using poly- and monoclonal filaggrin antibodies.The immunoreactivity for filaggrin was significantly more intense in the oral
for infections with significantly higher risk in the glucocorticoid-exposed population ranged from 2.01 (95% CI 1.83-2.19; p < 0.001) for cutaneous cellulitis to 5.84 (95% CI 5.61-6.08; p < 0.001) for lower respiratory tract infection (LRTI). There was no difference in the risk of scabies, dermatophytosis and varicella. The relative increase in risk was stable over the durations of exposure, except for LRTI and local candidiasis, for which it was much higher during the first weeks of exposure. The risks (...) or varicella, which may have led to limited statistical power.The relative risk of LRTI and local candidiasis is very high during the first weeks of glucocorticoid exposure. Further studies are needed to assess whether low albumin level is a risk factor for infection by itself (e.g., by being associated with a higher free glucocorticoid fraction) or whether it reflects other underlying causes of general debilitation.
in volume (millilitre [mL]) [ Time Frame: Week 52 or prematurely discontinued from the trial, whichever occur first ] Secondary Outcome Measures : Change in dyspnea from baseline as measured by the Mahler Transition Dyspnea Index (TDI) [ Time Frame: at Week 52 ] Absolute change from baseline in St. George Respiratory Questionnaire (SGRQ) total score [ Time Frame: at Week 52 ] Absolute change from baseline in Modified Rodnan skin score (mRSS) at Week 52 in subjects with diffuse cutaneous skin involvement (...) Completion of oral anti-infectives within 2 weeks of Screening Use of oral anti-infectives during Screening Period Vaginal candidiasis onychomycosis chronically suppressed oral herpes simplex virus Prophylaxis for Pneumocystis jiroveci pneumonia History of/positive Human immunodeficiency virus, hepatitis C antibody and/or polymerase chain reaction or Hepatitis B surface antigen and/or hepatitis B core antibody (total and/or Immunoglobulin M) antibody at screening. History of/current diagnosis of active
of myotomy, innovative and less invasive, called POEM (PerOral Endoscopic Myotomy). This technique does not require any cutaneous incision. Mini-invasive surgery is more and more associated to endoscopy. The practice was initiated by the accession of natural orifice transluminal endoscopic surgery (NOTES). In this context, the introduction of the POEM technique seems to be an original approach and a natural evolution to a new generation of surgical endoscopy. Condition or disease Intervention/treatment (...) (EGD) Contraindication to general anesthesia BMI above 40 kg/m² Infectious esophagitis (e.g. candidiasis) Psychiatric context unsuitable with an experimental protocol Allergy to beta-lactam Contraindication to endoscopy (esophageal stenosis, suspicion of digestive perforation, state of shock, severe anemia, cardiorespiratory failure or severe metabolic disorders) Contraindication to monitored pneumoperitoneum (cardiorespiratory failure or severe metabolic disorders) Inability to give an informed